A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...

Over 50 dogs are participating in a clinical trial to study osteosarcoma that could lead to the development of a new treatment for humans.

The Northern Health and Social Care Trust has launched a new partnership with charity organisation Pets as Therapy, bringing ...

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...